Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Brain, Synapse
DISEASE(S): Alzheimer's Disease
SUBMITTER: Douglas Lamont
LAB HEAD: Tara Spires-Jones
PROVIDER: PXD013753 | Pride | 2020-05-26
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
ProteomicsResults2019.xlsx | Xlsx | |||
TW-1.raw | Raw | |||
TW-10.raw | Raw | |||
TW-11.raw | Raw | |||
TW-12.raw | Raw |
Items per page: 5 1 - 5 of 21 |
Hesse Raphael R Hurtado Maica Llavero ML Jackson Rosemary J RJ Eaton Samantha L SL Herrmann Abigail G AG Colom-Cadena Marti M Tzioras Makis M King Declan D Rose Jamie J Tulloch Jane J McKenzie Chris-Anne CA Smith Colin C Henstridge Christopher M CM Lamont Douglas D Wishart Thomas M TM Spires-Jones Tara L TL
Acta neuropathologica communications 20191220 1
Degeneration of synapses in Alzheimer's disease (AD) strongly correlates with cognitive decline, and synaptic pathology contributes to disease pathophysiology. We recently observed that the strongest genetic risk factor for sporadic AD, apolipoprotein E epsilon 4 (APOE4), is associated with exacerbated synapse loss and synaptic accumulation of oligomeric amyloid beta in human AD brain. To begin to understand the molecular cascades involved in synapse loss in AD and how this is mediated by APOE, ...[more]